TuesdayJul 17, 2012 8:16 am

MakeMusic, Inc. (MMUS) Receives Acquisition Proposal from LaunchEquity Partners, LLC

MakeMusic has confirmed that on July 15, 2012, it received an offer from LaunchEquity Partners, LLC for the acquisition of MakeMusic’s operating assets, excluding cash and liabilities, free and clear of all liens and encumbrances, for $13.5 million. The offer from LaunchEquity stipulates that MakeMusic would assume a plan of liquidation including the distribution of MakeMusic’s available cash reserves to existing shareholders. LaunchEquity and a group of its affiliates currently have a 27.7% ownership stake in MakeMusic’s outstanding common stock, according to the latest filings by LaunchEquity and its affiliates with the Securities and Exchange Commission. In accordance with MakeMusic’s…

Continue Reading

TuesdayJul 17, 2012 8:10 am

Additional Data Provided by Anthera Pharmaceuticals (ANTH) for Recently Completed PEARL-SC Study of Blisibimod

Yesterday, Anthera Pharmaceuticals, a biopharmaceutical company specializing in the development of drugs for treating serious diseases related to inflammation and autoimmune disorders, announced the final set of clinical data from its phase 2b PEARL-SC study in patients with systemic lupus erythematosus. The final data from the study with 200mg weekly blisibimod suggests sustained and greater treatment effects versus placebo utilizing 6-, 7-, and 8-point improvements in the SELENA-SLEDAI disease-scoring index. In the predefined population of patients that had severe disease and were also taking corticosteroids, the SRI-8 treatment benefit in the 200mg weekly blisibimod cohort was seen as early as…

Continue Reading

MondayJul 16, 2012 4:01 pm

Nova Mining Corp. (NVMN) President Comments on China Visit, Rising Demand for Lithium Products

Nova Mining, a mineral mining assets company with an acquisition-based growth strategy, today issued a press release regarding company President James Dilger’s visit to China, where he is meeting with battery manufacturers to negotiate lithium pricing. Dilger reports that since his arrival Friday, he has received several invites from battery companies in China. “They are very aggressive,” Dilger stated in the press release. “Lithium supply has certainly become a very hot issue here in China - especially in Shenzhen.” Dilger previously commented on the high demand for lithium products for the electronics production industry. “Phenomenal Apple (AAPL) iPad sales, exploding…

Continue Reading

MondayJul 16, 2012 12:48 pm

AxoGen, Inc. (AXGN) Makes Initial Commercial Shipment of Avance Nerve Graft to Distributor in Italy

AxoGen is a regenerative medicine company focused on the development and commercialization of products and technologies for peripheral nerve reconstruction and regeneration. Peripheral nerves are very important as they provide the pathways for both motor and sensory signals throughout the body. The company's portfolio of peripheral nerve-related products includes the Avance Nerve Graft, a allograft nerve for bridging nerve discontinuities (gaps created when nerves are severed) of 5-70 millimeters in length. By eliminating a second surgery to harvest the patient's own nerve tissue for use in the repair, the Avance Nerve Graft offers a viable alternative to traditional nerve repair…

Continue Reading

MondayJul 16, 2012 11:24 am

Applied Visual Sciences, Inc. (APVS) Saves Lives through Revolutionary Image Analysis

Applied Visual Sciences, an image analysis software technology company, has developed intelligent, cutting-edge imaging analytics and informatics technologies for extracting, analyzing, and detecting objects-of-interest within any still or video digital image format. The company has originated a pioneering technology platform for the automated analysis of digital imagery to extract information that can lead to the detection and identification of health-threatening diseases and explosive materials that threaten human safety and the security of critical infrastructure. Extraction of intelligence from digital images is continually being limited by the shortcomings of human vision. No amount of training can overcome or compensate for the…

Continue Reading

MondayJul 16, 2012 10:21 am

Studio One Media, Inc. (SOMD) Breakthrough Audio and Video Technologies to Transform Entertainment Industry

Studio One Media is a diversified media and technology company. Together with its wholly-owned subsidiaries, which include MyStudio, Inc. and MyStudio Audio Labs, Inc., the company is engaged in the research and development of proprietary, leading-edge audio and video technologies for professional and consumer use. Currently, the company has the ability to generate revenue from three key sources; MyStudio recording sessions, digital advertising and sponsorship opportunities, and mastering or “AfterMastering” of new music as well as existing catalog music. Studio One has extended its presence by establishing strategic partnerships with Simon Cowell's The X Factor, The Grammy Foundation, Mark Burnett…

Continue Reading

MondayJul 16, 2012 10:18 am

PolyMedix, Inc. (PYMX) Discusses Potential Benefits from GAIN

Friday, PolyMedix issued a press release that discussed potential benefits the company stands to gain from the passing of the Generating Antibiotics Incentives Now (GAIN) Act into law. The GAIN Act, signed into law last week, will provide incentives for the development of infectious disease products that qualify under the Act, including antibiotics intended to treat drug-resistant pathogens. PolyMedix is a clinical-stage biotechnology company that is focused on developing a new class of antimicrobial agents, known as cidins, for use in the treatment of serious infections. The first of this new class, brilacidin, imitates the mechanism of natural human immunity,…

Continue Reading

FridayJul 13, 2012 4:18 pm

RXi Pharmaceuticals Corp. (RXII) Appoints Seasoned Medical Experts to Scientific Advisory Board

Biotech company RXi Pharmaceuticals today announced Dr. Jeannette Graf and Dr. Leroy Young have been added to its Scientific Advisory Board where their experience and research expertise will contribute to the ongoing development of the company’s lead compound. Dr. Graf is a board certified, clinical and research dermatologist with a private practice in Great Neck, NY. She is an assistant clinical professor of Dermatology at the Mount Sinai School of Medicine in New York; an accomplished product developer; and author of best-selling Stop Aging, Start Living. Dr. Graf has made multiple television and news appearances on national news and popular…

Continue Reading

FridayJul 13, 2012 1:33 pm

STWA, Inc. (ZERO) Oil Viscosity Reduction Technology Approved for Phase II Field Loop Testing After Successful Lab Testing

STWA continues expanding their portfolio of proprietary applied oil and fuel delivery solutions (developed with and exclusively licensed from Temple University) for the multi-billion dollar oil pipeline and diesel engine markets, reporting today that China's biggest oil producer PetroChina and the China Petroleum Pipeline Administration's (CPP) lab testing of the company's Applied Oil Technology™ (AOT) has generated successful results, leading to approval for Phase II Field Loop Testing. Testing was specifically focused on three of China's most widely produced/consumed oil grades (Daqing, Changqing, and Venezuela crude oil) in order to examine the viscosity reduction capabilities of STWA's AOT technology across…

Continue Reading

FridayJul 13, 2012 11:16 am

Misonix, Inc. (MSON) Enters into Three-Year Distribution Agreement with Soelim

Misonix, a surgical device company based in Farmingdale NY, has agreed to a three-year exclusive distribution agreement with Korea-based Soelim Inc., which entitles Soelim the rights to sell and distribute the SonaStar® Ultrasonic Surgical Aspiration System and the BoneScalpel(TM) Ultrasonic Bone Cutting System. The agreement includes details surrounding minimum annual purchase requirements. Included in the deal are the following products and tools: • The SonaStar is used by neurosurgeons and general surgeons for quick and efficient removal of hard and soft tumors while sparing most vessels and other surrounding tissue. It is engineered to provide powerful and precise ultrasonic aspiration…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered